TLR3 agonists as immunotherapeutic agents

Immunotherapy. 2010 Mar;2(2):137-40. doi: 10.2217/imt.10.8.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Animals
  • Drug Delivery Systems
  • Fatigue Syndrome, Chronic / drug therapy
  • Humans
  • Immunity, Innate / drug effects
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use*
  • Immunotherapy / methods*
  • Inflammation
  • Interferon Inducers / pharmacology
  • Interferon Inducers / therapeutic use
  • Mice
  • Mice, Knockout
  • Poly I-C / pharmacology
  • Poly I-C / therapeutic use
  • Poly U / therapeutic use
  • RNA Virus Infections / immunology
  • RNA Viruses / immunology
  • RNA, Double-Stranded / immunology
  • Toll-Like Receptor 3 / agonists*
  • Toll-Like Receptor 3 / deficiency

Substances

  • Immunologic Factors
  • Interferon Inducers
  • RNA, Double-Stranded
  • TLR3 protein, human
  • TLR3 protein, mouse
  • Toll-Like Receptor 3
  • Poly U
  • poly(I).poly(c12,U)
  • Poly I-C